Multi-site point of care assessment of Abbott ID NOW rapid molecular test for SARS-CoV-2 in a low-prevalence setting

M Graham; S Muhi; T Hoang; SA Ballard; J McAuley; JC Kwong; DA Williamson; BP Howden

Journal article

Multi-site point of care assessment of Abbott ID NOW rapid molecular test for SARS-CoV-2 in a low-prevalence setting

M Graham, S Muhi, T Hoang, SA Ballard, J McAuley, JC Kwong, DA Williamson, BP Howden

Pathology | Published : 2021

DOI: 10.1016/j.pathol.2021.07.002

University of Melbourne Researchers

Stephen Muhi Author

Julie McAuley Author

Jason Kwong Author

Deborah Williamson Author

Grants

Funding Acknowledgements

This research was funded by the Medical Research Future Fund (MRFF) 2020 COVID-19 Diagnostics Grant Opportunity as part of the COVID-19 Strategic Planning and Delivery of Testing program and the Victorian Government Department of Health as part of the Doherty Institute Innovative Testing Program. The funders were not involved in data analysis or manuscript preparation. The authors state that there are no conflicts of interest to disclose.